|
|
Volumn 9, Issue 2, 2008, Pages 92-101
|
|
Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: A review of the current literature and recommendations for treatment
a
|
|
Author keywords
Docetaxel; Gemcitabine; Prophylactic cranial irradiation; Vinblastine
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CARBOPLATIN;
CETUXIMAB;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
ERLOTINIB;
ETOPOSIDE;
GEFITINIB;
GEMCITABINE;
LOMUSTINE;
NAVELBINE;
PACLITAXEL;
PEMETREXED;
PLACEBO;
PLATINUM;
TAXANE DERIVATIVE;
VINBLASTINE;
VINCA ALKALOID;
VINDESINE;
AREA UNDER THE CURVE;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL FEATURE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ESOPHAGITIS;
FEBRILE NEUTROPENIA;
HEALTH STATUS;
HUMAN;
INTERMETHOD COMPARISON;
LUNG NON SMALL CELL CANCER;
MEDICAL LITERATURE;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CYCLE TREATMENT;
PNEUMONIA;
RADIATION DOSE;
REVIEW;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 43049114973
PISSN: 15257304
EISSN: None
Source Type: Journal
DOI: 10.3816/CLC.2008.n.014 Document Type: Review |
|
Times cited : (26)
|
|
References (67)
|
